Drug Discovery Solutions

  1. NanoAssemblr® Spark™: Freedom To Discover 4/14/2022

    The NanoAssemblr® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales.

  2. Leveraging Proprietary CDO Platforms

    Explore how a suite of proprietary CDO platforms for BsAbs, transient expression, developability assessment, and more can help optimize every stage of development and accelerate your project timeline.

  3. Cell Line Development Solutions 5/15/2023

    Discover technology that enables a cost-effective, easily implemented cell line development workflow while delivering high productivity pools and cell lines.

  4. Transient Expression Platform: discoCHO 10/4/2024

    Learn how this transient platform accelerates biologics production, seamlessly transitioning from discovery to stable CHO-K1, ensuring scalability, and reducing risks in manufacturing therapeutic biologics.

  5. CHEF1™ Expression Technology 2/17/2022

    The platform accelerates development of cell lines for cGMP production by using robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and proprietary expression plasmids, to rapidly produce high levels of recombinant protein.

  6. Drug Substance Synthesis And Manufacturing 3/3/2022

    We take an agile and flexible approach with our customers programs, offering bespoke drug substance synthesis and manufacturing, helping to accelerate molecules from candidate selection to clinical proof-of-concept and onwards towards commercial scale.

  7. Phosphoramidite Chemistry Capabilities For Oligonucleotide Synthesis 6/18/2025

    Accelerate your research and development with high-quality, custom phosphoramidite synthesis backed by decades of proven chemistry and scalable precision.

  8. A Fully Integrated Toolbox For Therapeutic Protein Expression

    The GS Xceed® Gene Expression System is a comprehensive toolbox for development of biologics that has been used to develop not only monoclonal antibodies but also a wide variety of new molecular formats.

  9. Analytical Labs Particle Analysis

    Particulate in a drug product represents a huge risk not only to patient safety – but also to a drug company’s reputation and bottom line. As concern about particulate rises, partnering with a particle analysis team enables customers to gain an intimate understanding of particle sources related to packaging and delivery systems.

  10. Bridging Molecules From Early Discovery To POC And Beyond 1/2/2024

    Learn how this partnership improves flexibility for customers, offers dedicated project teams, and enables a bespoke service that is tailored to each development program.